Navigation Links
Global Acute Coronary Syndrome Industry
Date:6/28/2010

5

A GLOBAL MARKET REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

Acute Coronary Syndrome - A Primer II-1

Table 1: World Recent Past, Current & Future Analysis for

Acute Coronary Syndrome Therapeutics Market - Annual Revenues

in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) II-1

Global ACS Drugs Market Scenario II-2

Table 2: Leading ACS Drugs with Global Sales Revenues (in

US$ billion) for the Year 2008 (includes corresponding

Graph/Chart) II-3

Table 3: Select Leading Myocardial Infarction Drugs

Worldwide: Value Sales for 2007 and 2008 in US$ Million

(includes corresponding Graph/Chart) II-4

Table 4: Select Leading Coronary Artery Disease/

Atherosclerosis Drugs Worldwide: Value Sales for 2007 and

2008 in US$ Million (includes corresponding Graph/Chart) II-4

Table 5: Select Leading Angina Drugs Worldwide: Value Sales

for 2
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... August 31, 2015 ... OTCQX: BLGTY) ("BioLight" or the "Company"), a firm ... in ophthalmology and cancer diagnostics, today announced that ... has identified several new genetic markers with high ... patients treated with bisphosphonate drugs and was able ...
(Date:8/31/2015)... , Aug. 31, 2015  AMRI (NASDAQ: ... a strategic collaboration focused on the development, manufacture ... pharmaceutical ingredients, ("APIs"). The collaboration combines Saneca,s strength ... expertise in developing and manufacturing controlled substance APIs ... tech transfer processes into these facilities. The collaboration ...
(Date:8/31/2015)... and STAMFORD, Conn. , Aug. 31, ... Eisai Co., Ltd., and Purdue Pharma L.P. announced today ... for the development and commercialization of Eisai,s clinical candidate ... entering Phase III clinical development for the treatment of ... agreement, Eisai and Purdue Pharma will share the costs ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
... 2011 SV Life Sciences ("SVLS") today announced the ... SVLS in early 2009 as Venture Partner. ... tremendous experience with large-scale medical technology businesses to our ... Managing Partner. "In doing so, Paul has underscored a ...
... BROOK, N.J., Jan. 6, 2011 The FDA,s nod to ... they have to address the problems of sexual dysfunction. "So ... of Semprae Laboratories, Inc. The announcement of the approval of ... Flibanserin. Dubbed the "pink pill," the female Viagra equivalent, many ...
Cached Medicine Technology:SV Life Sciences Promotes 30-Year MedTech Veteran Paul LaViolette to Partner 2SV Life Sciences Promotes 30-Year MedTech Veteran Paul LaViolette to Partner 3What About Us? The State of Women's Sexual Health in Question 2
(Date:8/31/2015)... ... , ... Cosmetic Town Journal is an online plastic surgery ... successful cosmetic procedure; from publishing encyclopedic medical articles to inform patients and connecting ... help. , It is clear that the Cosmetic Town aesthetic surgery community has ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... include a wealth of information for specific translation services within the medical and ... an incredible track record of successful work. , ITC Global Translations specializes in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental clinicians ... University of Health Sciences to learn more about its integrated approach to diabetes ... Sciences and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, National ...
(Date:8/31/2015)... Beach, FL (PRWEB) , ... August 31, 2015 , ... ... of companies – has teamed up with fellow South Walton property management ... on eliminating extreme poverty in remote parts of the world. The two companies will ...
(Date:8/31/2015)... ... ... to undergoing a hair transplant, most patients have donor hair moved from one part of ... on top of the scalp, as well as filling in areas missing hair, is a ... areas of their head. , What about patients who have a limited, or even depleted, ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2
... Since antiquity, people have been fascinated with larger-than-life characters, ... Looking at the legions of fans mourning the loss ... a modern phenomenon. But from the gods on Olympus ... Sinatra in the 1950s to Brad and Angelina today, ...
... Continues as Growth of Company Exemplifies the Best in Retirement Living ... demand for senior housing will outpace supply in the coming years. Couple ... the future of the senior housing industry looks very different than it ... Aegis Living, a national leader in ...
... June 26 The Agency for Healthcare Research and Quality,s ... mixed reviews for the quality of care they provide. ... no state does well or poorly on all quality measures. ... Services is also releasing state-by-state reports on the health care ...
... deadlier than a heart attack, experts say, with chances for ... star Michael Jackson probably did not die on Thursday of ... sudden cardiac arrest, experts say. , It,s not yet clear ... Angeles home, but that assumption has been made by many ...
... , , Employers demonstrated commitment to making employee health ... 26 HealthFitness (NYSE Amex: FIT ) today ... as "2009 Best Employers for Healthy Lifestyles" by the National ... http://www.newscom.com/cgi-bin/prnh/20090122/CG61641LOGO ) , , According to the ...
... therapy, researchers say , FRIDAY, June 26 (HealthDay News) ... are more likely to have a level of arterial ... blood pressure, a new study finds. , Arterial stiffness ... high blood pressure. , The study provides new insight ...
Cached Medicine News:Health News:The Psychology of Celebrity Worship 2Health News:The Psychology of Celebrity Worship 3Health News:Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 2Health News:Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 3Health News:New Snapshots Show States Vary Widely in Providing Quality Health Care 2Health News:Jackson's Death Puts Spotlight on Sudden Cardiac Arrest 2Health News:Jackson's Death Puts Spotlight on Sudden Cardiac Arrest 3Health News:Several HealthFitness Clients Earn National Recognition for Employee Health Initiatives 2
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
... Modulus™ is a multifunctional ... to give you utmost ... luminescence, and absorbance. Modulus ... fluorometer, dedicated luminometer, or ...
Medicine Products: